Dry Eyes Disease Market Share, Trends, Size, Industry Analysis Report,

1. Dry Eyes Disease Market Size $431.7 Million By 2030 | CAGR: 7.7%

2. Dry Eyes Disease Market Size Worth $431.7 Million By 2030 | CAGR: 7.7% “As per Polaris Market Research report, The global dry eyes disease market is valued at US $225.6 million in 2021 and is expected to grow at a CAGR of 4.7% during the forecast period. In recent years, The Dry Eyes Disease Market report scrutinizes the present situation and development prognosis of the market. The report offers a complete knowledge of key parameters such as market size, share and growth, trends, cost structure, and comprehensive and statistical data in the global Ultraviolet disinfection equipment market. Also, the market overview section of the report holds an in-depth analysis of current and future trends, analyzing the data on a historical basis and forecasted data till the year 2030. The report traces key market drivers, covering potentially lucrative opportunities and challenges as well as drivers, obstacles, issues, and risks. Dry Eyes Disease Market Report Scope: The global Dry Eyes Disease Market is segmented by Component, Payment Method, Deployment Type, Industry Vertical and region. The research report analyzes the most important trends related to the different segments that help to explain the market. The report additionally surveys both developed & developing regions considered for global Dry Eyes Disease Market research. The regional analysis engages readers with a comprehensive overview of various countries and regions to help players plan effective expansion strategies. The report outlines the noteworthy factors, such as driving factors and challenges, that will explain the market’s future growth. Also, it covers an exhaustive coverage of major industry drivers, restraints, and their - 2 -

3. Dry Eyes Disease Market Size Worth $431.7 Million By 2030 | CAGR: 7.7% By Technology By Channel Distribution By Region By Application By Drug Type Urban Planning ADAS & Driverless Cars Corridor Mapping Environment Engineering Exploration Others ssive  · Artificial Tears  · Others Tear- stimulating  · Topical Corticosteroids  · Immunosuppre · Broadband light  · Meibomian Gland Expression  · Intense Pulsed Light  · Combination (MGX+IPL)  Hospital Pharmacies  · Retail Pharmacies  · Specialty clinics  · E-commerce  · Others North America (U.S., Canada) Europe (Germany, UK, France, Italy) Asia Pacific (China, India, Japan) Latin America (Brazil, Mexico) MEA impact on global Dry Eyes Disease Market growth during the forecast period from 2022-2030. The market research assists studying the key plans, initiatives, and strategies for the development of the market. COVID-19 Impact Analysis for Dry Eyes Disease Market The market has also been affected by the recent COVID-19 pandemic and is expected to experience its long- term effects over the forecast period. Extensive evaluation of the effect of the COVID-19 pandemic is given to uncover the major issues and potential paths forward. The report merges the customer spending habits, business target, dynamics of current market forces, re-routing of the supply chain, and competitors in the global Biosensors Marketas a thorough analysis. The report serves overall estimation, insights, and forecasts, considering the COVID-19 impact on the market. Gain access to our latest research report that includes in-depth analysis of the COVID-19 pandemic impacting the the Biosensors Marketacross different regions and how major players are building strategies to mitigate the adverse effect of the pandemic and take benefit of emerging opportunities - 3 -

4. Dry Eyes Disease Market Size Worth $431.7 Million By 2030 | CAGR: 7.7% Regional Outlook In terms of geography, the region dominated the market with its higher revenue share contribution. The driving factors for this regional market growth include the current technological advancements in the industry, growing economic stability, huge government investments, and rising awareness related to the benefits of the product/service. Browse Detailed Research Report On Dry Eyes Disease Market Analysis: Competitive Landscape The report completely profiles prominent market players or industrialists covering company profile, product specifications, production capacity/sales, revenue, price, and gross margin & sales. Here you will find a comprehensive analysis of the competitive landscape and detailed information on vendors and factors that will challenge the growth of major vendors. The section highlights key points such as regional segmentation, major investments, and details of historical, present, and projected revenues. the product portfolio, market explanation, and classification are indicated. According to Polaris Market Research, the leading players with a noteworthy dominance in the Dry Eyes Disease Market Abbott, AbbVie Inc., AFT Pharmaceuticals, Akorn Operating, Company LLC, Allergan, Allostera Pharma Inc., AstraZeneca, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, I-Med Pharma Inc., Johnson & Johnson Private Limited, Merck & Co., Inc., Merck KGaA, Novaliq GmbH, Novartis AG, Otsuka America, Pharmaceutical, Inc., Pfizer Inc., Sanofi, Santen Pharmaceuticals Co. Ltd., Teva Pharmaceutical Industries Ltd Request for sample: https://www.polarismarketresearch.com/industry-analysis/dry-eyes-disease-market/request-for-sample Table of Contents 1. Introduction 2. Report Description 3. Objectives of the Study 4. Market Scope 5. Assumptions 6. Stakeholders 7. Executive Summary 8. Market Highlights 9. Research Methodology 10. Overview 11. Data Mining 12. Data Sources - 4 -

5. Dry Eyes Disease Market Size Worth $431.7 Million By 2030 | CAGR: 7.7% 13. Primary Sources 14. Secondary Sources 15. Global Dry Eyes Disease Market Insights 16. Dry Eyes Disease – Industry Snapshot 17. Dry Eyes Disease Market Dynamics 18. Drivers and Opportunities 19. Rising number of contact lens wearers 20. Increasing usage of visual display terminals 21. Restraints and Challenges 22. Presence of several contraindication pertaining to intense pulsed light 23. Porter’s Five Forces Analysis 24. Bargaining Power of Suppliers (Moderate) 25. Threats of New Entrants: (Low) 26. Bargaining Power of Buyers (Moderate) 27. Threat of Substitute (Moderate) 28. Rivalry among existing firms (High) 29. PESTEL Analysis 30. Dry Eyes Disease Market Industry Trends 31. Value Chain Analysis 32. COVID-19 Impact Analysis 33. Global Dry Eyes Disease Market, by Drug Type 34. Key Findings 35. Introduction 36. Global Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 37. Tear-stimulating 38. Global Dry Eyes Disease Market, by Tear-stimulating, by Region, 2018 - 2030 (USD Million) 39. Topical Corticosteroids 40. Global Dry Eyes Disease Market, by Topical Corticosteroids, by Region, 2018 - 2030 (USD Million) 41. Immunosuppressive 42. Global Dry Eyes Disease Market, by Immunosuppressive, by Region, 2018 - 2030 (USD Million) 43. Artificial Tears 44. Global Dry Eyes Disease Market, by Treatment, by Region, 2018 - 2030 (USD Million) 45. Others 46. Global Dry Eyes Disease Market, by Others, by Region, 2018 - 2030 (USD Million) 47. Global Dry Eyes Disease Market, by Technology 48. Key Findings 49. Introduction 50. Global Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 51. Broadband light 52. Global Dry Eyes Disease Market, by Broadband light, by Region, 2018 - 2030 (USD Million) 53. Meibomian Gland Expression 54. Global Dry Eyes Disease Market, by Meibomian Gland Expression, by Region, 2018 - 2030 (USD Million) 55. Intense Pulsed Light 56. Global Dry Eyes Disease Market, by Intense Pulsed Light, by Region, 2018 - 2030 (USD Million) 57. Combination (MGX+IPL) 58. Global Dry Eyes Disease Market, by Combination (MGX+IPL), by Region, 2018 - 2030 (USD Million) 59. Global Dry Eyes Disease Market, by Distribution Channel - 5 -

6. Dry Eyes Disease Market Size Worth $431.7 Million By 2030 | CAGR: 7.7% 60. Key Findings 61. Introduction 62. Global Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 63. Hospitals 64. Global Dry Eyes Disease Market, by Hospitals, by Region, 2018 - 2030 (USD Million) 65. Hospital Pharmacies 66. Global Dry Eyes Disease Market, by Hospital Pharmacies, by Region, 2018 - 2030 (USD Million) 67. Retail Pharmacies 68. Global Dry Eyes Disease Market, by Retail Pharmacies, by Region, 2018 - 2030 (USD Million) 69. Specialty clinics 70. Global Dry Eyes Disease Market, by Specialty clinics, by Region, 2018 - 2030 (USD Million) 71. E-commerce 72. Global Dry Eyes Disease Market, by E-commerce, by Region, 2018 - 2030 (USD Million) 73. Others 74. Global Dry Eyes Disease Market, by Others, by Region, 2018 - 2030 (USD Million) 75. Global Dry Eyes Disease Market, by Geography 76. Key findings 77. Introduction 78. Dry Eyes Disease Market Assessment, By Geography, 2018 - 2030 (USD Million) 79. Dry Eyes Disease Market – North America 80. North America: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 81. North America: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 82. North America: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 83. Dry Eyes Disease Market – U.S. 84. U.S.: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 85. U.S.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 86. U.S.: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 87. Dry Eyes Disease Market – Canada 88. Canada: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 89. Canada.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 90. Canada: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 91. Dry Eyes Disease Market – Europe 92. Europe: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 93. Europe.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 94. Europe: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 95. Dry Eyes Disease Market – UK 96. UK: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 97. UK.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 98. UK: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 99. Dry Eyes Disease Market – France 100. France: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 101. France.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 102. France: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 103. Dry Eyes Disease Market – Germany 104. Germany: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 105. Germany.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 106. Germany: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 107. Dry Eyes Disease Market – Italy 108. Italy: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) - 6 -

7. Dry Eyes Disease Market Size Worth $431.7 Million By 2030 | CAGR: 7.7% 109. Italy.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 110. Italy: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 111. Dry Eyes Disease Market – Spain 112. Spain: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 113. Spain.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 114. Spain: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 115. Dry Eyes Disease Market – Netherlands 116. Netherlands: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 117. Netherlands.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 118. Netherlands: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 119. Dry Eyes Disease Market – Russia 120. Russia: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 121. Russia.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 122. Russia: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 123. Dry Eyes Disease Market – Asia Pacific 124. Asia Pacific: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 125. Asia Pacific.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 126. Asia Pacific: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 127. Dry Eyes Disease Market – China 128. China: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 129. China.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 130. China: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 131. Dry Eyes Disease Market – India 132. India: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 133. India.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 134. India: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 135. Dry Eyes Disease Market – Malaysia 136. Malaysia: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 137. Malaysia.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 138. Malaysia: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 139. Dry Eyes Disease Market – Japan 140. Japan: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 141. Japan.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 142. Japan: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 143. Dry Eyes Disease Market – Indonesia 144. Indonesia: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 145. Indonesia.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 146. Indonesia: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 147. Dry Eyes Disease Market – South Korea 148. South Korea: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 149. South Korea.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 150. South Korea: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 151. Dry Eyes Disease Market – Middle East & Africa 152. Middle East & Africa: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 153. Middle East & Africa.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) - 7 -

8. Dry Eyes Disease Market Size Worth $431.7 Million By 2030 | CAGR: 7.7% 154. Middle East & Africa: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 155. Dry Eyes Disease Market – Saudi Arabia 156. Saudi Arabia: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 157. Saudi Arabia.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 158. Saudi Arabia: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 159. Dry Eyes Disease Market – UAE 160. UAE: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 161. UAE.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 162. UAE: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 163. Dry Eyes Disease Market – Israel 164. Israel: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 165. Israel.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 166. Israel: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 167. Dry Eyes Disease Market – South Africa 168. South Africa: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 169. South Africa.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 170. South Africa: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 171. Dry Eyes Disease Market – Latin America 172. Latin America: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 173. Latin America.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 174. Latin America: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 175. Dry Eyes Disease Market – Mexico 176. Mexico: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 177. Mexico.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 178. Mexico: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 179. Dry Eyes Disease Market – Brazil 180. Brazil: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 181. Brazil.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 182. Brazil: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 183. Dry Eyes Disease Market – Argentina 184. Argentina: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 185. Argentina.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 186. Argentina: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 187. Competitive Landscape 188. Expansion and Acquisition Analysis 189. Expansion 190. Acquisitions 191. Partnerships/Collaborations/Agreements/Exhibitions 192. Company Profiles 193. Abbott 194. Company Overview 195. Financial Performance 196. Product Benchmarking 197. Recent Development 198. AbbVie Inc. 199. Company Overview 200. Financial Performance - 8 -

9. Dry Eyes Disease Market Size Worth $431.7 Million By 2030 | CAGR: 7.7% 201. Product Benchmarking 202. Recent Development 203. AFT Pharmaceuticals 204. Company Overview 205. Financial Performance 206. Product Benchmarking 207. Recent Development 208. Akorn Operating 209. Company Overview 210. Financial Performance 211. Product Benchmarking 212. Recent Development 213. Company LLC 214. Company Overview 215. Financial Performance 216. Product Benchmarking 217. Recent Development 218. Allergan 219. Company Overview 220. Financial Performance 221. Product Benchmarking 222. Recent Development 223. Allostera Pharma Inc. 224. Company Overview 225. Financial Performance 226. Product Benchmarking 227. Recent Development 228. AstraZeneca 229. Company Overview 230. Financial Performance 231. Product Benchmarking 232. Recent Development 233. Eli Lilly and Company 234. Company Overview 235. Financial Performance 236. Product Benchmarking 237. Recent Development 238. F. Hoffmann-La Roche Ltd. 239. Company Overview 240. Financial Performance 241. Product Benchmarking 242. Recent Development 243. GlaxoSmithKline plc 244. Company Overview 245. Financial Performance 246. Product Benchmarking 247. Recent Development 248. I-Med Pharma Inc. 249. Company Overview 250. Financial Performance 251. Product Benchmarking 252. Recent Development - 9 -

10. Dry Eyes Disease Market Size Worth $431.7 Million By 2030 | CAGR: 7.7% 253. Johnson & Johnson Private Limited 254. Company Overview 255. Financial Performance 256. Product Benchmarking 257. Recent Development 258. Merck & Co., Inc. 259. Company Overview 260. Financial Performance 261. Product Benchmarking 262. Recent Development 263. Merck KGaA 264. Company Overview 265. Financial Performance 266. Product Benchmarking 267. Recent Development 268. Novaliq GmbH 269. Company Overview 270. Financial Performance 271. Product Benchmarking 272. Recent Development 273. Novartis AG 274. Company Overview 275. Financial Performance 276. Product Benchmarking 277. Recent Development 278. Otsuka America 279. Company Overview 280. Financial Performance 281. Product Benchmarking 282. Recent Development 283. Pharmaceutical, Inc. 284. Company Overview 285. Financial Performance 286. Product Benchmarking 287. Recent Development 288. Pfizer Inc. 289. Company Overview 290. Financial Performance 291. Product Benchmarking 292. Recent Development 293. Sanofi 294. Company Overview 295. Financial Performance 296. Product Benchmarking 297. Recent Development 298. Santen Pharmaceuticals Co. Ltd. 299. Company Overview 300. Financial Performance 301. Product Benchmarking 302. Recent Development 303. Teva Pharmaceutical Industries Ltd 304. Company Overview - 10 -

11. Dry Eyes Disease Market Size Worth $431.7 Million By 2030 | CAGR: 7.7% 305. Financial Performance 306. Product Benchmarking 307. Recent Development 308. List of Tables 309. Table 1 Global Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 310. Table 2 Global Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 311. Table 3 Global Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 312. Table 4 Dry Eyes Disease Market Assessment, By Geography, 2018 - 2030 (USD Million) 313. Table 5 North America: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 314. Table 6 North America: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 315. Table 7 North America: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 316. Table 8 U.S.: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 317. Table 9 U.S.: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 318. Table 10 U.S.: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 319. Table 11 Canada: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 320. Table 12 Canada: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 321. Table 13 Canada: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 322. Table 14 Europe: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 323. Table 15 Europe: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 324. Table 16 Europe: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 325. Table 17 UK: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 326. Table 18 UK: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 327. Table 19 UK: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 328. Table 20 France: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 329. Table 21 France: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 330. Table 22 France: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 331. Table 23 Germany: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 332. Table 24 Germany: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 333. Table 25 Germany: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 334. Table 26 Italy: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 335. Table 27 Italy: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 336. Table 28 Italy: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 337. Table 29 Spain: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 338. Table 30 Spain: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 339. Table 31 Spain: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 340. Table 32 Netherlands: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 341. Table 33 Netherlands: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) - 11 -

12. Dry Eyes Disease Market Size Worth $431.7 Million By 2030 | CAGR: 7.7% 342. Table 34 Netherlands: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 343. Table 35 Russia: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 344. Table 36 Russia: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 345. Table 37 Russia: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 346. Table 38 Asia Pacific: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 347. Table 39 Asia Pacific: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 348. Table 40 Asia Pacific: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 349. Table 41 China: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 350. Table 42 China: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 351. Table 43 China: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 352. Table 44 India: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 353. Table 45 India: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 354. Table 46 India: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 355. Table 47 Malaysia: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 356. Table 48 Malaysia: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 357. Table 49 Malaysia: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 358. Table 50 Japan: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 359. Table 51 Japan: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 360. Table 52 Japan: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 361. Table 53 Indonesia: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 362. Table 54 Indonesia: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 363. Table 55 Indonesia: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 364. Table 56 South Korea: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 365. Table 57 South Korea: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 366. Table 58 South Korea: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 367. Table 59 Middle East & Africa: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 368. Table 60 Middle East & Africa: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 369. Table 61 Middle East & Africa: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 370. Table 62 Saudi Arabia: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 371. Table 63 Saudi Arabia: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 372. Table 64 Saudi Arabia: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 373. Table 65 UAE: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) - 12 -

13. Dry Eyes Disease Market Size Worth $431.7 Million By 2030 | CAGR: 7.7% 374. Table 66 UAE: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 375. Table 67 UAE: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 376. Table 68 Israel: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 377. Table 69 Israel: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 378. Table 70 Israel: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 379. Table 71 South Africa: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 380. Table 72 South Africa: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 381. Table 73 South Africa: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 382. Table 74 Latin America: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 383. Table 75 Latin America: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 384. Table 76 Latin America: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 385. Table 77 Mexico: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 386. Table 78 Mexico: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 387. Table 79 Mexico: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 388. Table 80 Brazil: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 389. Table 81 Brazil: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 390. Table 82 Brazil: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 391. Table 83 Argentina: Dry Eyes Disease Market, by Drug Type, 2018 - 2030 (USD Million) 392. Table 84 Argentina: Dry Eyes Disease Market, by Technology, 2018 - 2030 (USD Million) 393. Table 85 Argentina: Dry Eyes Disease Market, by Distribution Channel, 2018 - 2030 (USD Million) 394. List of Figures 395. Figure 1. Global Dry Eyes Disease Market, 2018 - 2030 (USD Million) 396. Figure 2. Integrated Ecosystem 397. Figure 3. Research Methodology: Top-Down & Bottom-Up Approach 398. Figure 4. Market by Geography 399. Figure 5. Porter’s Five Forces 400. Figure 6. Market by Technology 401. Figure 7. Global Dry Eyes Disease Market, by Technology, 2021 & 2030 (USD Million) 402. Figure 8. Market by Drug Type 403. Figure 9. Global Dry Eyes Disease Market, by Drug Type, 2021 & 2030 (USD Million) 404. Figure 10. Market by Distribution Channel 405. Figure 11. Global Dry Eyes Disease Market, by Distribution Channel, 2021 & 2030 (USD Million) 406. Figure 12. Dry Eyes Disease Market Assessment, By Geography, 2018 - 2030 (USD Million) 407. Figure 13. Strategic Analysis – Dry Eyes Disease Market 408. - 13 -

14. Dry Eyes Disease Market Size Worth $431.7 Million By 2030 | CAGR: 7.7% Access Press Release on Dry Eyes Disease Market: https://www.polarismarketresearch.com/checkouts/2971 About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 14 -